Indinavir - CAS 150378-17-9

Indinavir is an orally administered, specific HIV protease inhibitor commonly used in combination therapy as part of highly active antiretroviral therapy (HAART) for HIV/AIDS. Indinavir also inhibits the activation of MMP-2 in endothelial cells and exhibits affinity for α7-nAchR and SARS-CoV-2 Mpro.

SARS-CoV, MMP, Apoptosis, HIV Protease

Microbiology/Virology, Apoptosis, Proteases/Proteasome

150352

C36H47N5O4

613.79

N(C([C@H](CC1=CC=CC=C1)C[C@@H](CN2[C@H](C(NC(C)(C)C)=O)CN(CC=3C=CC=NC3)CC2)O)=O)[C@H]4C=5C(C[C@H]4O)=CC=CC5

-20°C

Ice Packs

Small Compound